Products
Zolera
Pharmacotherapeutic group
agents for the treatment of bone diseases; agents affecting bone structure and mineralization; bisphosphonatesInternational name
Zoledronic acidDosage form
Lyophilized for solution for infusionBone resorption inhibitor, nitrogen-containing bisphosphonate. Acts primarily on bone inhibiting osteoclast function and preventing bone resorption.
Apart from its inhibitory effect on bone resorption, zoledronic acid has antitumor properties ensuring its efficacy against bone metastases.